A cancer research company co-founded by Pediatrics and Human Development professor André Bachmann, PhD has been acquired by Lodo Therapeutics. There is some promise that with the New York biotech firm's resources, they can move novel therapies pioneered by MSU researchers into clinical trials. Read more here.